APP and amyloidosis: In our study, APP/Arg1 insufficient mice showed increased CD68 expression in HPC and ECX compared to APP/Arg1 sufficient mice and nTg/Arg1 insufficient mice, suggesting that amyloidosis and Arg1 deficiency promoted CD68 expression.